Single Dose Liposomal Bupivicaine — Competitive Intelligence Brief

Single Dose Liposomal Bupivicaine (Single Dose Liposomal Bupivicaine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic (liposomal formulation). Area: Anesthesia/Pain Management.

marketed Local anesthetic (liposomal formulation) Voltage-gated sodium channels Anesthesia/Pain Management Small molecule

Target snapshot

Single Dose Liposomal Bupivicaine (Single Dose Liposomal Bupivicaine) — University of California, Davis. Liposomal bupivacaine is a local anesthetic encapsulated in liposomes that provides prolonged nerve blockade by slowly releasing bupivacaine at the injection site.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Single Dose Liposomal Bupivicaine TARGET	Single Dose Liposomal Bupivicaine	University of California, Davis	marketed	Local anesthetic (liposomal formulation)	Voltage-gated sodium channels
Ropivacaine 0,75% in PENG block	Ropivacaine 0,75% in PENG block	University of Liege	marketed	Local anesthetic (amide)	Voltage-gated sodium channels
Ropivacaine 0.2% for S-ESPB	Ropivacaine 0.2% for S-ESPB	Poznan University of Medical Sciences	marketed	Local anesthetic (amide)	Voltage-gated sodium channels
Bupivacaine Hcl 0.75% Inj	Bupivacaine Hcl 0.75% Inj	Rothman Institute Orthopaedics	marketed	Local anesthetic	Voltage-gated sodium channels
Fentanyl and bupivacaine	Fentanyl and bupivacaine	Hospital Central Dr. Luis Ortega	marketed	Opioid analgesic combined with local anesthetic	Mu opioid receptor (fentanyl); voltage-gated sodium channels (bupivacaine)
Liposome bupivacaine	Liposome bupivacaine	Catherine Vandepitte, M.D.	marketed	Local anesthetic (liposomal formulation)	Voltage-gated sodium channels
SUP Lidocaine	SUP Lidocaine	University of Michigan	marketed	Local anesthetic	Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic (liposomal formulation) class)

1. Pacira Pharmaceuticals, Inc · 4 drugs in this class
2. Huazhong University of Science and Technology · 1 drug in this class
3. Maimonides Medical Center · 1 drug in this class
4. The Cleveland Clinic · 1 drug in this class
5. The Cooper Health System · 1 drug in this class
6. The University of Texas Health Science Center, Houston · 1 drug in this class
7. Tianjin Medical University General Hospital · 1 drug in this class
8. University of California, Davis · 1 drug in this class
9. Catherine Vandepitte, M.D. · 1 drug in this class
10. Wake Forest University Health Sciences · 1 drug in this class